Eric Shaff

Eric Shaff has an extensive work experience in various roles and companies. Eric started their career as a Senior Analyst at Broadview International and held this position from July 2002 to June 2004. Eric then joined Genzyme Corporation in March 2006 as a Finance Manager and later progressed to roles such as Associate Director of Corporate Development, Director of Corporate Development, and Vice President of Finance. Eric worked in Genzyme Corporation until December 2011. In January 2012, Eric joined Momenta Pharmaceuticals as the Vice President of Corporate Finance, serving until November 2014. From November 2014 to December 2017, they worked as the Chief Financial Officer at Seres Therapeutics. Following this, they served as the Chief Operating and Financial Officer of Seres Therapeutics from January 2018 to January 2019. Currently, Eric Shaff is the President and Chief Executive Officer at Seres Therapeutics, a position they have held since January 2019. Additionally, they have also served as the Corporate Director at Sigilon Therapeutics, Inc. since October 2017.

Eric Shaff earned their MBA in Finance from Cornell Johnson Graduate School of Management from 2002 to 2004. Prior to that, they pursued a Bachelor's degree in Economics and Political Science from the University of Pennsylvania, which they completed from 1994 to 1998. At the start of their education, Eric attended Belmont Hill from 1990 to 1994.